Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institut Pasteur d'Algérie (IPA) is a leading public health and research institution in Algeria, operating as an Industrial and Commercial Public Establishment (EPIC). Founded in 1894, it serves as the national reference laboratory and a major producer of biological products, including vaccines, antivenoms, and diagnostic reagents. The institute plays a critical role in epidemiological surveillance, public health research, and the distribution of medical supplies across the country. IPA is particularly known for its production of rabies vaccines and scorpion and snake antivenoms tailored to the North African region. It also provides specialized medical analysis and training for healthcare professionals, maintaining a key position within the international Pasteur Network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institut Pasteur d'Algérie.